SCHEMBL30194971

SCHEMBL30194971

Cn1ncc(P(C2CCCCC2)C2CCCCC2)c1C(=O)N(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 4/20 0.38
▸ CHRM3 P20309 4/20 0.38
▸ CHRM5 P08912 3/20 0.38
▸ CHRM1 P11229 3/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ PDE10A Q9Y233 2/20 0.36
▸ PKM P14618 2/20 0.34
▸ KMT2A Q03164 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29227813 0.81 S1PR3 (0.39) KMT2A
SCHEMBL30194933 0.81 LMNA (0.33) PDE10AALDH1A1POLB
SCHEMBL30195080 0.72 LMNA (0.48) ALDH1A1POLBSMN1; SMN2
SCHEMBL28841006 0.64 ADRA1A (0.38) KMT2AALDH1A1SMN1; SMN2
SCHEMBL29790554 0.64 ADRA1A (0.38) KMT2AALDH1A1SMN1; SMN2
SCHEMBL5266975 0.62 ALDH1A1 (0.43) KMT2AALDH1A1SMN1; SMN2
SCHEMBL1315359 0.61 ROCK2 (0.35) PKMKMT2AALDH1A1SMN1; SMN2
SCHEMBL29391340 0.61 ALDH1A1 (0.40) KMT2AALDH1A1POLBSMN1; SMN2
SCHEMBL29227809 0.61 GPR52 (0.46) CHRM4CHRM3CHRM5CHRM1CHRM2
SCHEMBL2847317 0.61 KDM4E (0.33) PKMKMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115703806-B Phosphine ligand of pyrazole-amide framework, and preparation method and application thereof 香港理工大学深圳研究院 2024-05-14 — — CN disclosed
CN-115703806-A Phosphine ligand with pyrazole-amide skeleton and preparation method and application thereof 香港理工大学深圳研究院 2023-02-17 — — CN disclosed
Send feedback